WHO ICTRP trial
Clinical Efficacy and Safety of the Combination of Polymyxin B plus Tigecycline…
ChiCTR1800019371 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR1800019371 |
|---|---|
| Public title | Clinical Efficacy and Safety of the Combination of Polymyxin B plus Tigecycline in the Treatment of hospital acquired pneumonia caused by Carbapenem-Resistant Enterobacteriaceae or Carbapenem-Resistant Acinetobacter baumannii. |
| Scientific title | Clinical Efficacy and Safety of the Combination of Polymyxin B plus Tigecycline in the Treatment of hospital acquired pneumonia caused by Carbapenem-Resistant Enterobacteriaceae or Carbapenem-Resistant Acinetobacter baumannii. |
| Primary sponsor | China-Japanese Friendship Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Observational study |
| Phase | Retrospective study |
| Countries | China |
| Conditions | Hospital acquired pneumonia |
| Interventions | Exposure group:Based on polymyxin B combined with Tigecycline treatment group;Control group:Treatment group based on polymyxin B;Control group:Treatment group based on Tigecycline |
| Registration date | Nov 7, 2018 |
| Target size | Exposure group:100;Control group:150;Control group:150 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: